In his current role at SIA ZIM Laboratories Limited, Mr. Prakash Sapkal leverages his extensive experience and expertise to spearhead strategic initiatives aimed at enhancing the company’s presence in the EU and regulated market sectors for the Oral Thin Film business. His leadership reflects SIA ZIM Laboratories’ commitment to excellence and innovation in pharmaceutical and nutraceutical development, seamlessly bridging his invaluable contributions to both ZIM Laboratories Limited and SIA ZIM Laboratories Limited.

Mr. Prakash Sapkal, a Pharmacy graduate with a postgraduate degree in Business Administration, has been with ZIM Laboratories Limited for over 27 years. Starting as an Assistant Chemist, he has progressed through the ranks, holding key positions including Production Supervisor, Production Manager and Vice President – Operations.

Mr. Zulfiquar Kamal, as the Director of Finance, Commercial, and Corporate Governance at SIA ZIM Laboratories Limited, exemplifies a commitment to financial integrity, commercial excellence, and robust corporate governance. Leveraging his extensive experience in finance and corporate affairs, he oversees strategic financial management, commercial operations, and governance practices to ensure profitability and compliance at SIA ZIM Laboratories Limited.

Mr. Zulfiquar Kamal, an experienced Chartered Accountant with over 30 years of diverse financial expertise, has been an integral part of ZIM Laboratories Limited for over 26 years. He has served on the Board of Directors since 1991 and has played a key role in strengthening financial discipline and internal controls, immensely contributing to the Company’s sustained growth.

Dr. Chandrashekhar Mainde, with an M. Pharm and Ph.D. in Pharmaceutical Technology, serves as a Director at SIA ZIM Laboratories Limited. He is the Technical Head of Marketing and Business Development for Regulated Markets, where he guides research and development initiatives. Leveraging his expertise, he leads efforts to navigate regulatory requirements, develop effective marketing strategies, and expand business opportunities within regulated markets. His active involvement in research and development underscores his commitment to driving innovation and advancing the company’s product portfolio.

Dr. Mainde brings over 25 years of R&D and global business development experience. He is associated with leading pharmaceutical organisations and holds a proven track record, having successfully undergone approximately 75 audits by major regulatory authorities, including the USFDA, MHRA, ANVISA, TGA and EMA. He has led the filing of over 300 products with Turkey’s Ministry of Health (MOH), 10 ANDA submissions to the USA, and 50 EU CTD dossiers across various European countries. He has also conducted over 300 bio-equivalence studies, including those involving complex formulations, and submitted approximately 150 ANDA applications in the USA and other regulated markets.